Stockwatch

If you had invested ₹10,000 in Glenmark Pharmaceuticals in 2016

Worth at the close on 30 Oct 2026
₹26,914
+169.1% Gain of ₹16,914 over 10.4 years.
Invested
₹10,000
On
19 May 2016
Price then
₹854.10
Price now
₹2,299
Annualised
+9.9%
Multiple
2.69×
₹0₹10,000₹20,000₹30,000201620182020202220242026
Glenmark Pharmaceuticals What you put in

Value of ₹10,000 invested on 19 May 2016, month by month.

Was that any good?

The same money, somewhere else

WhereWorth nowChange Against GLENMARK
Glenmark Pharmaceuticals ₹26,914 +169.1% —
Fixed deposit at 6.5% ₹19,308 +93.1% ₹7,606 more

The fixed deposit line assumes a steady 6.5% a year for the whole period. No bank held one rate that long: Indian deposit rates ran from around 9% in 2014 to about 5.5% in 2021. Treat it as a yardstick, not a record of what a deposit actually paid.

Year by year

YearChange
2026 +12.9%
2025 +26.5%
2024 +88.4%
2023 +101.3%
2022 -19.8%
2021 +7.1%

Glenmark Pharmaceuticals on the record

All-time high
₹2,515
28 Aug 2026
52-week range
₹1,793 – ₹2,538
Deepest fall
-80.5%
01 Nov 2016 to 23 Mar 2020
Market cap
₹64,875 Cr

How this was worked out

₹10,000 at ₹854.10 a share buys 11.71 shares. Held to the close of 30 Oct 2026 at ₹2,299, those shares are worth ₹26,914. Dividends are not included, and neither are brokerage, taxes or charges — the real figure would differ on both counts.

Data covers 19 May 2016 to 30 Oct 2026 (2,588 trading days), from end-of-day NSE prices. This page is a record of what prices did. It is not advice, and nothing here is a recommendation to buy or sell — read the disclaimer.

Companies of a similar size